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Abstract
This study aims to identify and understand factors associated with COVID-19 vaccine
acceptance during pregnancy and estimate COVID-19 vaccine coverage among pregnant East
Tennesseans. COVID-19 vaccination during pregnancy has been shown to be safe and effective
and is strongly recommended, as pregnant people are at increased risk of severe illness and death
from COVID-19 infection. At the national level, COVID-19 vaccine uptake among pregnant adults
was initially lower than that of US adults overall. Further, vaccination coverage in Tennessee lags
behind that in non-pregnant US adults overall and, to the best of our knowledge, COVID-19
vaccination coverage among pregnant people in East Tennessee is unknown. Identifying
contributors and barriers to vaccine acceptance among pregnant people will inform the
development of interventions to combat vaccine hesitancy among this high-risk population. A
cross-sectional survey assessing vaccine uptake and factors contributing to the decision to
vaccinate among pregnant people in East Tennessee was launched in February 2022 and is
currently ongoing. The preliminary data presented here were collected February 14, 2022, through
May 12, 2022. Of the n = 73 participants described here, 79.5% were vaccinated. Trust in medical
advice regarding COVID-19 infection and vaccination was low in those who were not yet
vaccinated and would not accept a COVID-19 vaccine, but the overall level of trust in prenatal
care providers was similar among those who would not accept a vaccine and those already
vaccinated against COVID-19.
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Introduction
Pregnant people are at increased risk of severe morbidity and death from COVID-19
infection [1-9]. COVID-19 infection during pregnancy has been associated with increased risk of
adverse outcomes such as maternal mortality, preeclampsia, and preterm birth [3, 4, 9-11]. One
study found that hospitalization associated with COVID-19 infection was 3.5 times higher among
pregnant adults with SARS-CoV2 infections than in similarly aged non-pregnant adults [3]. In a
multinational cohort study with over 2,000 participants in 18 countries, Villar et al. found that
pregnant people with a COVID-19 diagnosis during pregnancy were 22 times more likely to die
during or shortly after pregnancy compared to pregnant people without a COVID-19 diagnosis
during pregnancy [9]. Data also show that COVID-19 vaccination during pregnancy is effective
and safe for both mother and baby [12-18]. Further, COVID-19 vaccination during pregnancy
additionally confers protection to infants after birth [18-23]. Thus, COVID-19 vaccination during
pregnancy is strongly recommended [1, 10, 12, 19, 24-31].
At the national level, COVID-19 vaccine uptake among pregnant adults (approximately
70% as of March 2022) is lower than that of the general US adult population of reproductive age
(approximately 76% as of March 2022 [32]). Further, vaccination coverage in Tennessee lags
behind that in the US overall (approximately 59% of all adult Tennesseans ages 21-50 vaccinated
as of March 2022 [32]). To the best of our knowledge, COVID-19 vaccination coverage among
pregnant people in East Tennessee is unknown.
Vaccine uptake in pregnant people may lag behind non-pregnant adults due to several
factors, including that the vaccine was not recommended for pregnancy until later (recommended
for non-pregnant adults in December, 2020 and then pregnant adults in late April, 2021 [33]),
concern for the fetus and infant, and vaccine hesitancy. Vaccine hesitancy during pregnancy is
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documented, but COVID-19 vaccine uptake may be lower than for other vaccines during
pregnancy given several factors, including political influences, the relative overall newness of the
COVID-19 vaccine, and vaccine hesitancy independent of pregnancy [34]. Vaccination is a
complex decision-making process that is influenced by several contextual factors and purported to
be vaccine specific [35-38]. It has been proposed that trust in mainstream medicine and perceived
risk are critical components of vaccine hesitancy [35, 37-42]. The primary objective of this study
is to describe COVID-19 vaccine coverage and factors associated with COVID-19 vaccine uptake
among pregnant people in East Tennessee.
We anticipate that the study will find a lower prevalence of COVID-19 vaccination among
pregnant adults compared to the US and Tennessee general adult populations [32]. We anticipate
that COVID-19 vaccination will be associated with high levels of trust in mainstream medicine
and participants’ prenatal care provider, high perceived risk of severe COVID-19 infection, low
perceived risk of adverse outcomes from vaccination, and low levels of exposure to
misinformation. The preliminary data presented here were collected from February 14, 2022
through May 12, 2022, the study roll out period. They provide an estimate of the prevalence of
COVID-19 vaccination among pregnant individuals in East Tennessee and explore their trust in
medical providers for information on COVID-19 and the COVID-19 vaccines.

Research Design and Methods
Survey Design and Development
A cross-sectional, online, anonymous survey was developed using both pre-existing survey
instruments and original questions. We conducted a literature review to inform survey
development and consulted professionals in the field throughout survey development and

5
refinement. An approximately 140-question survey was developed and administered using
REDCap, a secure web-based application for building and managing online surveys and clinical
research databases that is compatible for use with mobile devices. The survey is presented in
Appendix A. The current report focuses on COVID-19 vaccination status and perceptions of the
COVID-19 vaccines and COVID-19 infection (including trust in primary and prenatal care
providers on these topics), The survey also assessed demographic information, acceptance and
perceptions of routine maternal vaccines (Tdap and flu vaccinations during pregnancy) and routine
childhood vaccines, history of confirmed or likely COVID-19 infection before or during the
current pregnancy, COVID-19 prevention behaviors, and pandemic-related stressors specific to
pregnancy (PREPS survey [43-45]). Figure 1 displays the Moms and Vaccines survey sections
and content. The institutional review board at the University of Tennessee Graduate School of
Medicine reviewed and approved this study (study #4868).
Section

Summary

I. Screening
Questions

Screens for eligibility (participants must live or receive medical care in East
Tennessee, be 18 years of age or older, be comfortable communicating in
English, must be currently pregnant, and must have a due date within 8
months of the date they begin the survey); participants must pass screening
questions to proceed

II. Consent to
Participate

Informed consent for participants; they must consent to proceed with survey

III. Demographic
Information

Demographic questions about study participants, including race and ethnicity,
marital status, household income, age, community type (urban/rural/suburban),
education level, and political affiliation

IV. Maternal
Vaccinations

Assesses uptake and perceptions of flu and Tdap vaccines during pregnancy,
two routine vaccinations that are recommended during pregnancy

V. Childhood
Vaccinations

Assesses perceptions and beliefs about routine childhood vaccinations [46, 47]

VI. COVID-19
Vaccines

Assesses uptake and perceptions about COVID-19 vaccines during and
related to pregnancy
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VII. COVID-19

Asks if participants have had or likely had prior COVID-19 infection (both
during and before current pregnancy), assesses participants’ level of trust in
their primary care and prenatal care providers regarding COVID-19 vaccines

VIII. COVID-19
Behaviors

Assesses what COVID-19 prevention behaviors participants engage in, such
as mask-wearing, social distancing, etc., and asks where participants get their
information about COVID-19 from

IX. Impacts of the
COVID-19 Outbreak
on You

Assesses the level of stress and the impacts of the COVID-19 outbreak on
participants; includes the Pandemic Related Pregnancy Stress Scale (PREPS)
[43-45]

X. Survey
Conclusion

Participants must choose to submit answers to research team or withdraw
from the study; those who submit can optionally continue to a separate survey
instrument to receive a $10 Walmart gift card for their time

XI. (Optional) Email
and Mailing
Address to Receive
Gift Card

Participants can submit a valid USPS mailing address and email address if
they want to receive a $10 Walmart gift card for completing the survey; this
information is not linked to their survey responses and is kept strictly
confidential

Figure 1. Moms and Vaccines Survey sections and summaries

The REDCap survey is compatible with mobile browsers and takes approximately 30
minutes to complete. Figure 2 displays the mobile browser version of the survey. Study
advertisements (displayed in Appendix B) contain a QR code and short URL
(redcap.link/momsandvaccines) that direct potential participants to the screening questions;
participants must pass all five screening questions and consent to participate in the study before
they proceed though the survey. The final question of the survey requires participants to confirm
they would like to submit their responses to the research team (versus withdraw from the study).
Participants who complete the survey and submit their responses to the research team then
have the option to continue to a separate REDCap survey, where they can enter a valid mailing
address and email address in order to receive a $10 Walmart gift card incentive. The incentive is
entirely optional, participants’ mailing address and email are not linked to their survey responses
in any way, and this information is stored in a separate REDCap database from the survey
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responses. Mailing addresses and email addresses remain strictly confidential and are used only to
distribute the gift card to those who opt-in to the incentive.
Setting and Sampling
Study data were collected and managed using REDCap electronic data capture tools hosted
at the University of Tennessee Graduate School of Medicine [48, 49]. REDCap (Research
Electronic Data Capture) is a secure, web-based software platform designed to support data capture
for research studies, providing 1) an intuitive interface for validated data capture; 2) audit trails for
tracking data manipulation and export procedures; 3) automated export procedures for seamless
data downloads to common statistical packages; and 4) procedures for data integration and
interoperability with external sources.
We launched the Moms and Vaccines Survey
beginning in late February 2022. This report presents
preliminary data from the role out of the Moms and Vaccines
Survey (i.e., between February 14, 2022 and May 12, 2022).
Participants were eligible to participate if they were (selfreported): comfortable communicating in English (to
complete the survey), 18 years of age or older, currently
pregnant, live or receive medical care in East Tennessee, and
had a due date within eight months of the day they began the
survey. Participants were recruited via posters and flyers
placed primarily in hospital and clinic waiting rooms (see
Appendix B). During the role out period, advertising efforts
were focused within the University of Tennessee Medical

Figure 2. Moms and Vaccines
Survey display on a mobile phone
browser at start of survey
(screening questions)
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Center (UTMC) and its satellite clinics, namely University Women’s Specialists (UWS). UTMC
is an academic, regional, quaternary care medical center located in urban Knoxville, Tennessee.
UTMC serves 21 counties in the East Tennessee region and serves as a regional referral center for
East Tennessee [50]; UTMC delivers approximately 4,000 infants annually.
Data Analysis
Participants were dichotomized based on their reported COVID-19 vaccination status. The
responses of those who indicated that they have already received a COVID-19 vaccine (the
“vaccinated” group, n = 58) were compared to those who indicated that they have not yet received
a COVID-19 vaccine and would not receive a COVID-19 vaccine (the “declining vaccination”
group, n = 11). Participants who answered, “Yes, I would accept a COVID-19 vaccine, but I have
not been vaccinated yet,” (n = 4) were excluded from this analysis due to the small sample size.
Figure 3 provides an overview of the study design and stratification scheme. Further, data on
perceptions of the risks of COVID-19 infection and vaccination, and medical information from,
discussions with, and level of trust in healthcare providers, are also presented, by vaccination
status.

Figure 3. Overview of methods and analysis. Pregnant people (N = 73) who reported that they live
or receive medical care in East Tennessee took the mobile REDCap Moms and Vaccines Survey
and could optionally receive a $10 Walmart gift card for their time. For data analysis, respondents
were separated based on their reported vaccination status: already vaccinated against COVID-19
(n = 58, “vaccinated”), not yet vaccinated against COVID-19 but willing to receive a COVID vaccine
(n = 4), or not vaccinated against COVID-19 and not willing to receive a COVID vaccine (n = 11,
“declining vaccination”). The vaccinated and declining vaccination groups were compared.
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To assess perceptions of the risks of COVID-19 infection and vaccination, participants
rated their level of agreement with several statements about COVID-19 infection and vaccination
on a Likert scale (statements are shown in Appendix A, section E). The answer choices on the
Likert scale were: 1) strongly agree, 2) agree, 3) not sure or neutral, 4) disagree, and 5) strongly
disagree. To describe responses to these questions, an answer of “strongly agree” or “agree” was
considered affirmative, while an answer of “not sure or neutral,” “disagree,” or “strongly disagree”
was considered to not affirm the statement. Table 2 displays participants’ agreement with these
statements, stratified by vaccination status.
Participants were also asked to rate their level of trust in both their primary care provider
and their prenatal care provider on a scale from 0-100, 0 being “not at all trust” and 100 being
“trust completely.” These reported levels of trust were compared between vaccination groups using
a one-sided, two-sample, independent t-test (alternative hypothesis of the declining vaccination
group having lower average trust than the vaccinated group).
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Results
Characteristic
COVID-19 Vaccination Status
Vaccinated
Not vaccinated and would accept a vaccine
Not vaccinated and would not accept a vaccine
Age
21-25
26-30
31-35
36-42
Race and Ethnicity
White
Non-White
Missing
Education
High school or GED
Technical/trade school, some college, or 2-year degree
4-year college graduate
Postgraduate
Community Type
Urban
Suburban
Rural
Don’t know
Marital Status
Married/civil union
Political Affiliation
None/unaffiliated/independent/moderate
Democrat/progressive
Republican/conservative
Missing
Table 1. Characteristics of Moms and Vaccines Study participants (N = 73)

n (%)
58 (79.5)
11 (15.1)
4 (5.5)
15 (20.5)
20 (27.4)
27 (37.0)
11 (15.1)
61 (83.6)
11 (15.1)
1 (1.4)
3 (4.1)
16 (21.9)
28 (38.4)
26 (35.6)
8 (11.0)
42 (57.5)
20 (27.4)
3 (4.1)
62 (84.9)
14 (19.2)
21 (28.8)
20 (27.4)
18 (24.7)
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Vaccinated
(N = 58)

Would not
accept vaccine
(N = 11)

The COVID-19 vaccine will affect their fertility

4 (6.9%)

6 (54.5%)

COVID-19 vaccination during pregnancy will increase the
risk of miscarriage or spontaneous abortion

2 (3.4%)

4 (36.4%)

Receiving a COVID-19 vaccine during pregnancy is
unlikely to protect the baby from COVID-19

4 (6.9%)

5 (45.5%)

Receiving COVID-19 vaccine during pregnancy will harm
their baby

2 (3.4%)

5 (45.5%)

It is safe to receive a COVID-19 vaccine during
pregnancy

42 (72.4%)

0 (0.0%)

COVID-19 infection will be more severe if they do not get
the COVID vaccine

54 (93.1%)

0 (0.0%)

The COVID-19 vaccine will lead to a COVID infection

1 (1.8%)

4 (36.4%)

COVID-19 vaccines were developed too quickly to be
safe and effective

6 (10.3%)

7 (63.6%)

COVID-19 vaccines could alter DNA

1 (1.7%)

4 (36.4%)

The risks of the COVID-19 vaccine are greater than the
risks of infection with COVID-19

2 (3.4%)

9 (81.8%)

48 (82.8%)

0 (0.0%)

Vaccinated
(N = 58)

Would not
accept vaccine
(N = 11)

Trust information about COVID-19 vaccination from their
primary care provider

51 (87.9%)

1 (9.1%)

Can openly discuss concerns about COVID-19
vaccination with their primary care provider

52 (89.7%)

6 (54.5%)

Trust information about COVID-19 vaccination from their
prenatal care provider

54 (93.1%)

1 (9.1%)

Feel that they can openly discuss their concerns about
COVID-19 vaccination with their prenatal care provider

58 (100.0%)

8 (72.7%)

Baby is at increased risk of infection if others in their
household do not get the COVID-19 vaccine

Table 2. Perceptions of the risks of infection and vaccination

Table 3. Medical information and discussions with providers
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Participant characteristics are

A

displayed in Table 1. The prevalence of
COVID-19 vaccination among Moms
and Vaccines study participants was
found to be 79.5%. Perceptions of the
risks

of

COVID

infection

and

vaccination are displayed in Table 2.

B

The three most prevalent concerns
reported

among

those

declining

vaccination were: concerns about the
vaccine’s effects on fertility, the belief
Figure 4. Reported overall levels of trust in primary care
providers (A) and prenatal care providers (B) on a scale
from 0-100 (0 = not at all trust to 100 = completely trust)

that

COVID-19

vaccines

were

developed too quickly, and belief that
the

risks

of

COVID-19

vaccines

outweigh the risks of COVID-19 infection. Reported perceptions about providers are displayed in
Table 3. Participants declining vaccination reported lower trust in information about COVID-19
infection and vaccination than vaccinated participants. However, those declining vaccination
indicated that they feel that they can openly discuss their concerns about COVID-19 vaccination
with their prenatal care provider.
The distribution in level of trust in primary care providers and prenatal care providers for
the vaccinated and declining vaccination groups are displayed in Figure 4. There was a statistically
significant lower level of trust in primary care providers in the declining vaccination group
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compared to the vaccinated group, with a P-value of 0.0466. No difference in average level of trust
in prenatal care providers was detected between the two groups, with a P-value of 0.0730. This
indicates a lack of trust in the medical establishment among those declining vaccination.
The survey also included several open-ended questions where participants could provide
additional information on why they chose to receive or not receive a COVID-19 vaccine. The
responses were reviewed to identify themes related to perceptions of and trust in medical providers
related to COVID-19 and COVID-19 vaccination. Figure 5 and Figure 6 display themes identified
and direct quotes that summarize these responses.
Is there anything you would like to tell us about why you chose to receive the COVID19 vaccine?
Theme 1: Protection for self and others; sense of responsibility or duty
“I am concerned about my own health, but particularly about the odds of my spreading
covid to someone in a high-risk population”
“For my health and my family’s health. To do my part for the country. For the safety of my
students.”
“It is the socially responsible thing to do”
“Seemed safer than taking the risk of getting COVID-19, especially with members of our
family being high-risk”
Theme 2: Received a COVID-19 vaccine, but still hesitant or newly hesitant
“I would probably not have it if it wasn’t required at work”
“I was told that it would not have any [effects] on fertility and would help protect me from
covid, but after more information came out after I got the vaccine that the [effects] on
fertility are more concerning. Since I am not at risk due to underlying conditions I did not
receive a booster shot.”
Figure 5. Themes in responses about why participants who are already vaccinated chose to
receive a COVID-19 vaccine
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Please tell us why you would not accept a COVID-19 vaccine.
Theme 1: Vaccine development was “rushed,” there is not yet enough research on vaccine
safety and side effects
“It was too rushed and not enough research”
“It was produced very quickly under unprecedented circumstances and there is a lot of
anecdotal concern about side effects”
“this vaccine hasn’t had the time to be properly studied yet for long term side effects. No
one is able to tell me for sure what potential side effects there are 5-10 years down the
road. At this time, the benefits of the vaccine do not outweigh the risks for me”
“The COVID19 shots on the market are still in the trial phase and I believe there has not
been enough research on side effects regarding these shots and dosages.”
Theme 2: COVID vaccine is ineffective or is not needed because of protection afforded from
prior COVID infection
“I feel that the covid vaccine is not truly a vaccine at all, but rather a therapeutic treatment.
I work [in health care] and have seen for myself how the covid vaccine has been largely
ineffective in preventing the catching and spreading of the illness.”
“The immunity I have [received] from contracting the virus gives me safer protection and
antibodies than the COVID19 shot.”
“I contracted covid in July 2020 (during the delta surge), and thus have some protection
from the antibodies created during that time.”
Theme 3: “Personal choice” or opinion
“Personal choice”
“I do not agree with this trial vaccine”
“I do not believe in it”
“don’t want [to]”
Theme 4: Mistrust in institutions
“I’m not convinced the CDC is being forthright about [side effects of the vaccine] based on
my conversations with medical professionals.”
“There are too many requirements concerning the Covid vaccine, and too many people
are strongly benefitting financially. If there is a strong (financial) motive, I am reluctant to
trust those who push the idea.”
Figure 6. Themes in responses about why participants declining vaccination would not
accept a COVID-19 vaccine

Discussion
The reported COVID-19 vaccination coverage among Moms and Vaccines participants
during the roll out period was 79.5%. This number is higher than we expected. We believe that our
early advertising efforts (in the Medical Center) may have resulted in selection bias, as a majority
or survey respondents were white, highly educated, married people who live in suburban areas.
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We aim to expand our advertising and recruitment efforts to diversify our sample while
significantly increasing our sample size. One way we plan to do this is by modifying the study to
include social media advertising, which we have already obtained IRB approval for and plan to
implement in the coming weeks. We have also been in contact with doulas and midwives in East
Tennessee and in an effort to recruit participants who receive prenatal care from doulas, midwives,
and other providers, in addition to those whose care is received primarily from physicians in a
hospital or clinic setting.
The preliminary data also show important differences in the vaccinated and vaccine
declining groups. Those declining vaccination demonstrated greater levels of misinformation and
beliefs inconsistent with the scientific evidence about COVID-19 infection and vaccines, such as
high perceived risk of vaccination, low perceived risk of infection, and concerns about the
vaccine’s effects on fertility, which have been disproven [51]. Likewise, those already vaccinated
demonstrated beliefs about COVID-19 infection and vaccination more consistent with scientific
evidence such as lower perceived risk of COVID-19 vaccination and higher perceived risk of
infection. This supports our hypothesis that those who accept COVID-19 vaccines will
demonstrate high perceived risk of severe COVID-19 infection, low perceived risk of adverse
outcomes from vaccination, and low levels of exposure to misinformation.
Further, the majority of those vaccinated against COVID-19 expressed that they trust the
information they receive about COVID-19 infection and vaccines from both their primary and
prenatal care providers (87.9% and 93.1%, respectively) and feel that they can openly discuss their
concerns about infection and vaccination with both provider types (89.7% for primary care
providers and 100% for prenatal care providers). On the other hand, only 9.1% of those declining
vaccination expressed that they trust the information they receive about COVID-19 infection and
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vaccination from both primary care providers and prenatal care providers. Interestingly, however,
72.7% of those declining vaccination reported that they felt they can openly discuss their concerns
about COVID-19 vaccination with their prenatal care providers, compared to 54.5% who felt they
could discuss their concerns with their primary care provider. This suggests that prenatal care
provider-based interventions could be a promising strategy for increasing COVID-19 vaccine
uptake among pregnant people, if planning an intervention in a traditional medical care setting.
This also supports our hypothesis that COVID-19 vaccine uptake among pregnant people is
associated with trust in mainstream medicine and participants’ prenatal care provider.
Similarly, when reported level of overall trust in primary care and prenatal care providers
was assessed on a scale from 0-100, we found no significant difference in overall levels of trust in
prenatal care providers between the vaccinated and vaccine declining groups. However, we did
find statistically significant lower trust in primary care providers for the declining vaccination
group. This further suggests that prenatal care providers could be more valuable, in terms of
medical center-based interventions, to increase COVID-19 vaccine uptake among pregnant people.
Greater trust in prenatal care providers could be due to the increased number of visits with prenatal
care providers throughout pregnancy (a relatively narrow window) as compared to the frequency
of visits with a primary care provider. Increased visits and interactions allow patients and prenatal
care providers to build stronger patient-provider relationships and establish greater trust. One thing
we are interested in exploring in the future is the type of prenatal care providers (e.g., physician,
midwife, doula) that patients most trust and are most open to receiving information about COVID19 vaccination from.
Additionally, given that fertility was one of the top three concerns that stood out among
those declining vaccination, we would like to further investigate these concerns about fertility and
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possible health system-based interventions to dispel misinformation surrounding COVID-19
vaccines’ impact on fertility. Obstetrician-gynecologists could discuss COVID-19 vaccination
prior to pregnancy and assure patients that COVID-19 vaccines have no impact on their fertility.
Further, we wonder what specific concerns those declining vaccination hold about fertility since
they have already achieved pregnancy.

Conclusions
The study is ongoing, thus formal statistical testing across the full range of survey
constructs will be performed at its conclusion. These preliminary descriptive analyses of the Moms
and Vaccines study roll out data suggest that COVID-19 vaccination among pregnant people may
be higher than hypothesized and associated with greater trust in mainstream medicine and
healthcare providers, as well as perceived risk of adverse outcomes due to COVID-19 infection
and an understanding of vaccine safety consistent with scientific evidence. Those declining
vaccination reported much lower levels of trust in medical advice regarding COVID-19 infection
and vaccination, but similar levels of trust in their prenatal care provider overall when compared
to the vaccinated group. This indicates that prenatal care provider-based interventions may be a
promising health system-based strategy to address the unique concerns of this population and
increase COVID-19 vaccine uptake.
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APPENDIX A: Moms and Vaccines Survey
*All survey questions are displayed in the survey PDF file, so branching logic and skip patterns
are not displayed in the exported survey as participants would see them within the online survey
instrument.

APPENDIX B: Survey recruitment materials (poster and two-sided flyer)

